Total Payments
$241.36
2021 Payments
$25.61
Companies
6
Transactions
7
Medicare Patients
318,121
Medicare Billing
$29.2M
Payment Breakdown by Category
Food & Beverage$241.36 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $241.36 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $93.00 | 1 | $0 (2017) |
| Medtronic USA, Inc. | $66.89 | 2 | $0 (2017) |
| Zealand Pharma US, Inc. | $25.61 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.79 | 1 | $0 (2018) |
| ConvaTec Inc. | $20.51 | 1 | $0 (2017) |
| Roche Diagnostics Corporation | $11.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $25.61 | 1 | Zealand Pharma US, Inc. ($25.61) |
| 2018 | $23.79 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($23.79) |
| 2017 | $191.96 | 5 | Stryker Corporation ($93.00) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/08/2021 | Zealand Pharma US, Inc. | ZEGALOGUE (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: 1 | ||||||
| 01/02/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2017 | ConvaTec Inc. | AQUACEL AG (Device) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: WOUND THERAPEUTICS | ||||||
| 05/03/2017 | Stryker Corporation | Makoplasty (Device) | Food and Beverage | Cash or cash equivalent | $93.00 | General |
| Category: KNEES, HIPS | ||||||
| 03/02/2017 | Medtronic USA, Inc. | ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/14/2017 | Roche Diagnostics Corporation | TD BenchMark Platforms (Device) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Tissue Diagnostics | ||||||
| 01/31/2017 | Medtronic USA, Inc. | ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $51.23 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 75,083 | 114,490 | $20.6M | $6.8M |
| 2022 | 39 | 87,580 | 132,103 | $24.6M | $8.0M |
| 2021 | 39 | 95,133 | 132,584 | $25.2M | $8.3M |
| 2020 | 33 | 60,325 | 75,433 | $18.3M | $6.1M |
Total Patients
318,121
Total Services
454,610
Medicare Billing
$29.2M
Procedure Codes
151
All Medicare Procedures & Services
151 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87506 | Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets | Office | 2023 | 11,998 | 12,554 | $8.3M | $3.2M | 39.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 5,397 | 16,524 | $3.2M | $548,555 | 17.3% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 1,140 | 15,591 | $1.4M | $535,390 | 39.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 2,850 | 6,800 | $1.5M | $448,316 | 29.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 2,510 | 5,238 | $1.4M | $328,565 | 22.9% |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | Office | 2023 | 1,365 | 1,595 | $575,606 | $222,634 | 38.7% |
| 88120 | Cell examination of urine, manual | Office | 2023 | 329 | 378 | $628,035 | $195,256 | 31.1% |
| 83993 | Stool calprotectin (protein) level | Office | 2023 | 9,369 | 9,834 | $505,920 | $188,818 | 37.3% |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | Office | 2023 | 1,204 | 1,686 | $316,125 | $123,921 | 39.2% |
| 82656 | Detection of pancreatic elastase (enzyme) in stool | Office | 2023 | 8,428 | 8,702 | $250,879 | $98,144 | 39.1% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 962 | 1,427 | $250,186 | $98,054 | 39.2% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 968 | 2,832 | $248,023 | $97,258 | 39.2% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 179 | 724 | $335,318 | $94,580 | 28.2% |
| 87209 | Special stain for parasites | Office | 2023 | 3,704 | 3,845 | $183,199 | $67,577 | 36.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 1,115 | 1,279 | $164,095 | $64,268 | 39.2% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 191 | 193 | $184,379 | $42,889 | 23.3% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2023 | 1,202 | 1,682 | $105,125 | $41,209 | 39.2% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 842 | 970 | $175,678 | $39,672 | 22.6% |
| 83631 | Stool lactoferrin (immune system protein) level | Office | 2023 | 1,931 | 2,007 | $104,235 | $38,564 | 37.0% |
| 87338 | Detection test by immunoassay technique for helicobacter pylori (gi tract bacteria) in stool | Office | 2023 | 2,407 | 2,472 | $98,164 | $34,729 | 35.4% |
| 87177 | Smear for parasites | Office | 2023 | 3,693 | 3,918 | $98,937 | $34,080 | 34.4% |
| 87324 | Detection test by immunoassay technique for clostridium difficile toxins (stool pathogen) | Office | 2023 | 2,694 | 2,905 | $96,080 | $34,064 | 35.5% |
| 87507 | Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets | Office | 2023 | 66 | 66 | $68,769 | $26,957 | 39.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 185 | 279 | $85,511 | $22,579 | 26.4% |
| 82705 | Stool fat or lipids analysis, qualitative | Office | 2023 | 3,995 | 4,115 | $62,023 | $20,535 | 33.1% |
About Mohammad Qureshi
Mohammad Qureshi is a Specialist healthcare provider based in Edison, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174525604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mohammad Qureshi has received a total of $241.36 in payments from pharmaceutical and medical device companies, with $25.61 received in 2021. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($241.36).
As a Medicare-enrolled provider, Qureshi has provided services to 318,121 Medicare beneficiaries, totaling 454,610 services with total Medicare billing of $29.2M. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Edison, NJ
- Active Since 08/15/2005
- Last Updated 04/28/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174525604
Products in Payments
- Makoplasty (Device) $93.00
- ADAPTIVESTIM (Device) $66.89
- ZEGALOGUE (Drug) $25.61
- XIFAXAN (Drug) $23.79
- AQUACEL AG (Device) $20.51
- TD BenchMark Platforms (Device) $11.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Edison
Dr. Steven Escaldi, D.o, D.O
Specialist — Payments: $97,831
Specialist $97,831
Dr. Igor Sobol, M.d, M.D
Specialist — Payments: $56,320
Specialist $56,320
Mr. Robert Paull, M.d, M.D
Specialist — Payments: $28,417
Specialist $28,417
Dr. Robert Czyzewski, M.d, M.D
Specialist — Payments: $11,595
Specialist $11,595
Dr. Joseph Strauch, M.d, M.D
Specialist — Payments: $7,127
Specialist $7,127
Vincent Donnabella, M.d, M.D
Specialist — Payments: $6,721
Specialist $6,721